COVID-19 Funding opportunities 

  • As a reminder, conducting on-campus research requires approval during the lock down period.  Click here for more information.
  • For COVID-19 proposal development questions and support, please contact Katie Pizer, BSD Executive Director for Research Administration:    
  • To collaborate with other scientists across UChicago and the National Labs who are working on COVID-related research, complete a COVID Faculty Intake Form
  • The BSD Funding Opportunities website lists additional agency, UChicago, and BSD notices and guidelines. 

Last updated: April 22, 2021

Adira FoundationAdira's Fast-Track Grant Response: COVID-19
(Alzheimer’s, ALS, Huntington’s, multiple sclerosis, and Parkinson’s)
Biomedical Advanced Research and Development Authority (BARDA) BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency AnnouncementContinuous
Bloomberg PhilanthropiesCoronavirus Local Response InitiativeContinuous
CiscoPandemic/COVID19 Science, Technology and Social ImpactRolling
Defense Logistics AgencyRequest for White Papers: COVID-19 Prototype PPE and Decontamination EquipmentRolling
Gilead Sciences, Inc./ Gilean Sciences Pty LtdInvestigator Sponsored Research (ISR) Continuous
GoogleCOVID-19 Related Research credits available from Google Cloud
Research involving the use of patient data, including de-identified data, cannot be considered for this opportunity. Please inform BSD Information Security of your use of Google Cloud resources by emailing:
KaggleCOVID-19 Open Research Dataset Challenge (CORD-19)Open
Merck KGaAResearch Grant for Pandemic PreparednessRolling
National Science Foundation (NSF)Rapid Response Research (RAPID) Funding Mechanism
National Science Foundation (NSF)Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)Rapid Proposals; Check with program officers
National Science Foundation (NSF) NSF Rapid Release Funding MechanismRolling
NIHNotice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health DisparitiesOpen through 05/01/2021
NIHEmergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)See Emergency Notice of Special Interest by IC
NIH - NIDCDNotice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders09/08/2022
NIH - NCATSNotice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Needmultiple deadlines; see opportunity
NIH - NCATSEmergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel CoronavirusOpen through 01/26/2022
NIH - NIA and NIMHNotice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)05/01/2021
NIH - NIAID and NIAInvestigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)01/13/2021, 05/13/2021, 09/13/2021, 01/13/2022, 05/13/2022
NIH - NIEHSNotice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)05/04/2021
NovartisNovartis US COVID-19 InitiativeContinuous
Robert Wood Johnson FoundationPioneering Ideas: Exploring the Future to Build a Culture of HealthContinuous
The COVID-19 High Performance Computing (HPC) ConsortiumThe COVID-19 High Performance Computing Consortium Continuous
US ArmyArmy Applications Lab: Call for COVID-19 ProposalsContinuous
NIH, NIMHD, NCI, NIDA, NLM, ODP, OBSSR, NIMH, NIAMSNotice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health DisparitiesContinuous
NIH, NIAID Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)Continuous
NIH, NIADNotice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2Continuous
NIH, NCATSNotice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath NeedVarious
Expires July 10, 2021
NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSCEmergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)Various
NIH, NCI, NHGRI, NCCIH, NINDS, ORIP, NIMHD, NIA, NIDCR, NIAID, NIAMS, NIEHS, NCATS, NIDCD, NICHD, NIDDK, NHLBINotice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project7/12/2021
NIH, NIAID Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)7/01/2021
Department of StateCOVID-19 Private Sector Engagement & Partnership Fund5/28/2021